Literature DB >> 20663978

Estrogen stimulates the expression of mismatch repair gene hMLH1 in colonic epithelial cells.

Peng Jin1, Xiao-juan Lu, Jian-qiu Sheng, Lei Fu, Xiao-ming Meng, Xin Wang, Tai-ping Shi, Shi-rong Li, Jianyu Rao.   

Abstract

Estrogen is reported to have a protective effect on colon cancer; however, the underlying mechanism is unclear. Impaired mismatch repair plays an important role in colonic carcinogenesis. The purpose of this study was to investigate the association of estrogen on regulating mismatch repair expression in colonic epithelial cells. In cultured COLO205 cells, the effect of estradiol (E2) and antagonist ICI182.780 on the expression of hMLH1 and hMSH2 was studied using reverse transcription-PCR and Western blotting. The correlation between serum level E2 and the expression of hMLH1 and hMSH2 in colonic mucosal tissue of 42 healthy individuals was also examined using reverse transcription-PCR and immunohistochemical staining. E2 increased the expression of hMLH1 in COLO205 cells, which was suppressed by ICI182.780. However, the effect of E2 on hMSH2 expression was not significant in COLO205 cells. In healthy individuals, a strong positive correlation of E2 level with hMLH1 expression in normal colonic epithelial cell was observed when serum E2 level was >45 pg/mL, but no correlation was seen between E2 and hMSH2 expression. E2 affects the expression of hMLH1 but not hMSH2 in vitro, and high serum E2 level correlates with hMLH1 expression in vivo. These findings suggest that the anticolonic cancer effect of estrogen may be related to hMLH1 regulation. 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663978     DOI: 10.1158/1940-6207.CAPR-09-0228

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  13 in total

1.  Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer.

Authors:  Sonja Neumeyer; Odilia Popanda; Dominic Edelmann; Katja Butterbach; Csaba Toth; Wilfried Roth; Hendrik Bläker; Ruijingfang Jiang; Esther Herpel; Cornelia Jäkel; Peter Schmezer; Lina Jansen; Elizabeth Alwers; Axel Benner; Barbara Burwinkel; Michael Hoffmeister; Hermann Brenner; Jenny Chang-Claude
Journal:  Epigenetics       Date:  2019-03-30       Impact factor: 4.528

2.  Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.

Authors:  Karin Edvardsson; Anders Ström; Philip Jonsson; Jan-Åke Gustafsson; Cecilia Williams
Journal:  Mol Endocrinol       Date:  2011-04-14

3.  Gender and cell-type-specific effects of the transcription-coupled repair protein, ERCC6/CSB, on repeat expansion in a mouse model of the fragile X-related disorders.

Authors:  Xiao-Nan Zhao; Karen Usdin
Journal:  Hum Mutat       Date:  2014-03       Impact factor: 4.878

Review 4.  Advances in the study of Lynch syndrome in China.

Authors:  Jun-Yu Lu; Jian-Qiu Sheng
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

5.  Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression.

Authors:  Jennifer H Lin; Teppei Morikawa; Andrew T Chan; Aya Kuchiba; Kaori Shima; Katsuhiko Nosho; Gregory Kirkner; Shumin M Zhang; Joann E Manson; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  Cancer Res       Date:  2012-04-17       Impact factor: 12.701

Review 6.  Estrogen receptor beta as target for colorectal cancer prevention.

Authors:  Cecilia Williams; Alfredo DiLeo; Yaron Niv; Jan-Åke Gustafsson
Journal:  Cancer Lett       Date:  2015-12-18       Impact factor: 8.679

7.  Estradiol regulates miR-135b and mismatch repair gene expressions via estrogen receptor-β in colorectal cells.

Authors:  Yu-qi He; Jian-qiu Sheng; Xian-long Ling; Lei Fu; Peng Jin; Lawrence Yen; Jianyu Rao
Journal:  Exp Mol Med       Date:  2012-12-31       Impact factor: 8.718

8.  Estrogen and progesterone-related gene variants and colorectal cancer risk in women.

Authors:  Jennifer H Lin; JoAnn E Manson; Peter Kraft; Barbara B Cochrane; Marc J Gunter; Rowan T Chlebowski; Shumin M Zhang
Journal:  BMC Med Genet       Date:  2011-05-31       Impact factor: 2.103

9.  Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.

Authors:  Jenny Brändstedt; Sakarias Wangefjord; Björn Nodin; Jakob Eberhard; Karin Jirström; Jonas Manjer
Journal:  BMC Cancer       Date:  2014-05-25       Impact factor: 4.430

10.  Mismatch Repair Protein hMLH1, but not hMSH2, Enhances Estrogen-Induced Apoptosis of Colon Cancer Cells.

Authors:  Peng Jin; De-Zhi Wang; Chen-Xi Lyu; Ya-Ting Wang; Yu-Qi He; Jian-Qiu Sheng; Xuhang Li
Journal:  J Cancer       Date:  2017-09-15       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.